Form 4: Inovio Pharmaceuticals Director Roger Dansey Reports Stock Transactions

Director Roger Dansey reports the vesting and subsequent disposal of restricted stock units into common stock of Inovio Pharmaceuticals.

Summary

• On May 21, 2025, Roger Dansey, a director of Inovio Pharmaceuticals, reported transactions involving the company's stock.
• Dansey vested 2,167 restricted stock units, each representing a contingent right to receive one share of common stock.
• Simultaneously, Dansey disposed of 2,167 shares of common stock.
• Following these transactions, Dansey beneficially owns 8,916 shares of Inovio Pharmaceuticals.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company director.
• The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates

Keywords

Inovio Pharmaceuticals, INO, Roger Dansey, Form 4, Stock Transaction, Restricted Stock Units, Beneficial Ownership, Director